Avid Bioservices, Inc. (CDMO): Price and Financial Metrics

CDMO POWR Grades

• CDMO scores best on the Sentiment dimension, with a Sentiment rank ahead of 68.49% of US stocks.
• CDMO's strongest trending metric is Stability; it's been moving up over the last 178 days.
• CDMO's current lowest rank is in the Quality metric (where it is better than 6.49% of US stocks).

CDMO Stock Summary

• Of note is the ratio of AVID BIOSERVICES INC's sales and general administrative expense to its total operating expenses; 87.09% of US stocks have a lower such ratio.
• The ratio of debt to operating expenses for AVID BIOSERVICES INC is higher than it is for about 86.91% of US stocks.
• With a price/sales ratio of 7.91, AVID BIOSERVICES INC has a higher such ratio than 85.95% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to AVID BIOSERVICES INC, a group of peers worth examining would be SGBX, WORX, JUPW, LEN, and CDAY.
• CDMO's SEC filings can be seen here. And to visit AVID BIOSERVICES INC's official web site, go to avidbio.com.

CDMO Valuation Summary

• CDMO's price/sales ratio is 7.9; this is 315.79% higher than that of the median Healthcare stock.
• CDMO's EV/EBIT ratio has moved up 275.8 over the prior 243 months.

Below are key valuation metrics over time for CDMO.

CDMO Growth Metrics

Its 3 year net cashflow from operations growth rate is now at 181.63%.
• Its 3 year revenue growth rate is now at 123.12%.
• The 3 year price growth rate now stands at 279.25%.

Over the past 15 months, CDMO's revenue has gone up $32,953,000.

The table below shows CDMO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	134.183	-2.967	118.254
2022-06-30	125.535	11.373	122.932
2022-03-31	119.597	9.465	127.672
2021-12-31	115.977	26.713	9.775
2021-09-30	106.275	26.71	8.292
2021-06-30	101.23	26.513	5.612

CDMO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CDMO has a Quality Grade of C, ranking ahead of 27.37% of graded US stocks.
• CDMO's asset turnover comes in at 0.495 -- ranking 83rd of 682 Pharmaceutical Products stocks.
• COCP, HROW, and IBIO are the stocks whose asset turnover ratios are most correlated with CDMO.

The table below shows CDMO's key quality metrics over time.